SIRT1/HIF-1α pathway
The SIRT1/HIF-1α pathway is a signaling axis in which the NAD⁺-dependent deacetylase Sirtuin 1 (Sirt1) regulates the stability and transcriptional activity of Hypoxia-inducible factor 1-alpha (HIF-1α), linking cellular energy and redox state to the response to low oxygen.
The SIRT1/HIF-1α pathway is a signaling axis in which the NAD⁺-dependent deacetylase Sirtuin 1 (Sirt1) regulates the stability and transcriptional activity of Hypoxia-inducible factor 1-alpha (HIF-1α), linking cellular energy and redox state to the response to low oxygen. Sirt1 senses the NAD⁺/NADH ratio and deacetylates histone and non-histone substrates, including transcription factors such as FOXO3 and TP53. HIF-1α is the oxygen-labile subunit of the HIF-1 heterodimer: under normoxia it is hydroxylated by prolyl hydroxylases and degraded via the von Hippel-Lindau ubiquitin ligase, whereas under hypoxia it is stabilized, dimerizes with HIF-1β, and drives transcription of genes governing glycolysis, angiogenesis, and cell survival, notably VEGF and the glycolytic enzyme PKM2. Because Sirt1 activity depends on NAD⁺ and hypoxic metabolic reprogramming shifts NAD⁺ availability, the two arms of the axis are reciprocally coupled, making the pathway a node where metabolic supply, oxygen sensing, and gene expression are integrated.
This position at the interface of metabolism and stress signaling makes the pathway relevant across ischemic, inflammatory, fibrotic, metabolic, and neoplastic conditions, and both arms are pharmacologically tractable. In cerebral ischemia and ischemia-reperfusion injury, HIF-1α stabilization influences angiogenesis, blood–brain barrier integrity, and matrix metalloproteinase-9 activity, while Sirt1 activation is associated with reduced oxidative stress and apoptosis through effects on reactive oxygen species, superoxide dismutase, catalase, glutathione, heme oxygenase 1, and caspase-3. Sirt1 signaling also restrains NLRP3 inflammasome activation and the downstream caspase-1–dependent release of IL-1β and IL-18, a mechanism invoked in arthritis, steatohepatitis, and neuroinflammation, and it intersects with TGF-β1/SMAD signaling in fibrosis and with Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)/mTOR and GSK-3β signaling in cell survival and metabolic adaptation. In tumors, HIF-1α-driven glycolysis and angiogenesis contribute to therapy resistance and shape responses to modalities such as photodynamic and photochemotherapy and to cytotoxic agents including doxorubicin and cisplatin. Interventions used to probe or manipulate the axis include Sirt1 activators such as resveratrol, NAD⁺ precursors such as nicotinamide mononucleotide, and a range of plant-derived compounds and HIF-directed agents.
Where the papers sit
13 papers from the last 6 months study SIRT1/HIF-1α pathway directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 human data · 8 preclinical · 4 unclassified
Themes one subject · 1 paradigm shift
Those 13 are all about one subject.
-
Disease Mechanisms and Therapy
Natural compounds and metabolic interventions are being used to modulate SIRT1/HIF-1α-linked disease biology rather than treat downstream symptoms alone. Recurring mechanisms include glycolysis, CPT1A and carnitine metabolism, mitochondrial function, fibrosis, angiogenesis, and Th17 or M2 macrophage polarization. Reported benefits span liver, heart, brain, lung, joint, nerve, and tumor models, with resveratrol, ginsenosides, Panax notoginseng, and other agents predominating. Evidence remains largely preclinical, while biomarker studies and mechanotherapeutic delivery point toward clinical translation.
HIF-1α activation or stabilization, rather than suppression, can protect the ischemic brain
Danshen–Chuanxiong treatment in a cerebral ischemia model and SLK targeting in cerebral ischemia-reperfusion injury independently associate neuroprotection with activating CPT1/HIF-1α signaling or promoting USP8-mediated HIF-1α stabilization, respectively 42431282Jul 42387373Jul. This reverses the suppressive therapeutic framing used in other disease models, where reducing HIF-1α signaling is linked to improved pathology, and indicates that the pathway’s therapeutic direction depends on the ischemic context: preserving or enhancing HIF-1α activity may support recovery rather than worsen disease.
Papers
The 13 papers from the last 6 months that study SIRT1/HIF-1α pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Disease Mechanisms and Therapy (13)
- Indole-3-carbaldehyde mitigates fibrosis progression in MASH with T2DM via the SIRT1/TGF-β/SMAD signaling pathway. Biochimica et biophysica acta. Molecular basis of disease · 11 Jul 2026 PMID 42435945
- Danshen-Chuanxiong alleviates cerebral ischemia by regulating carnitine metabolism and angiogenesis via activating CPT1/HIF-1α signaling axis. Journal of ethnopharmacology · 10 Jul 2026 PMID 42431282
- Effects of interstitial photodynamic therapy on transplanted tumors of human lung adenocarcinoma A549 cells in nude mice. Lasers in medical science · 10 Jul 2026 PMID 42429993
- Panax notoginseng saponins (PNS)alleviates rheumatoid arthritis by regulating HIF-1α/PKM2-mediated glycolysis to inhibit Th17 differentiation. Molecular biology reports · 10 Jul 2026 PMID 42429989
- Nicotinamide mononucleotide ameliorates high glucose/high fat-induced cardiomyocyte metabolic dysfunction through SIRT1-mediated CPT1A stabilization. Molecular biology reports · 10 Jul 2026 PMID 42429864
- Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ1-42-Induced Alzheimer's Disease Model Mice. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 7 Jul 2026 PMID 42412302
- Targeting SLK protects against cerebral ischemia-reperfusion injury by regulating USP8-mediated HIF-1α stabilization and RhoA/ROCK activation. Cellular & molecular biology letters · 2 Jul 2026 PMID 42387373
- Mechanotherapeutic biomaterials: Overcoming physical barriers to enhance intratumoral drug delivery in solid tumours. Biomedical microdevices · 23 Jun 2026 PMID 42334617
- Ophiopogon japonicus alleviates pulmonary fibrosis through modulation of HIF1A/TUBB3 axis-associated M2 macrophage polarization and arginine metabolic alterations. Journal of ethnopharmacology · 12 Jun 2026 PMID 42285238
- Activation of Sirt1 by Glyasperin F Suppresses PI3K/Akt/HIF-1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis-Associated Interstitial Lung Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 30 May 2026 PMID 42216775
- CTRP3 alleviates neuropathic pain by improving mitochondrial biogenesis and mitochondrial unfolded protein response via spinal SIRT1 in rats. International journal of molecular medicine · 22 May 2026 PMID 42169654
- Ginsenoside Rg3 potentiates cisplatin antitumor activity while mitigating nephrotoxicity through SIRT1‑mediated suppression of the NLRP3 inflammasome. International journal of molecular medicine · 22 May 2026 PMID 42169649
- Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network Analysis. Molecular neurobiology · 21 May 2026 PMID 42168722
By study type
Human data, design not indexed (1)
- Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network Analysis. Molecular neurobiology · 21 May 2026 PMID 42168722
Preclinical: animal, cell and lab studies (8)
- Effects of interstitial photodynamic therapy on transplanted tumors of human lung adenocarcinoma A549 cells in nude mice. Lasers in medical science · 10 Jul 2026 PMID 42429993
- Panax notoginseng saponins (PNS)alleviates rheumatoid arthritis by regulating HIF-1α/PKM2-mediated glycolysis to inhibit Th17 differentiation. Molecular biology reports · 10 Jul 2026 PMID 42429989
- Nicotinamide mononucleotide ameliorates high glucose/high fat-induced cardiomyocyte metabolic dysfunction through SIRT1-mediated CPT1A stabilization. Molecular biology reports · 10 Jul 2026 PMID 42429864
- Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ1-42-Induced Alzheimer's Disease Model Mice. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 7 Jul 2026 PMID 42412302
- Mechanotherapeutic biomaterials: Overcoming physical barriers to enhance intratumoral drug delivery in solid tumours. Biomedical microdevices · 23 Jun 2026 PMID 42334617
- Activation of Sirt1 by Glyasperin F Suppresses PI3K/Akt/HIF-1α Signaling and Inhibits Glycolytic Metabolism to Ameliorate Pathology in Rheumatoid Arthritis-Associated Interstitial Lung Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 30 May 2026 PMID 42216775
- CTRP3 alleviates neuropathic pain by improving mitochondrial biogenesis and mitochondrial unfolded protein response via spinal SIRT1 in rats. International journal of molecular medicine · 22 May 2026 PMID 42169654
- Ginsenoside Rg3 potentiates cisplatin antitumor activity while mitigating nephrotoxicity through SIRT1‑mediated suppression of the NLRP3 inflammasome. International journal of molecular medicine · 22 May 2026 PMID 42169649
Unclassified: not yet indexed with MeSH (4)
- Indole-3-carbaldehyde mitigates fibrosis progression in MASH with T2DM via the SIRT1/TGF-β/SMAD signaling pathway. Biochimica et biophysica acta. Molecular basis of disease · 11 Jul 2026 PMID 42435945
- Danshen-Chuanxiong alleviates cerebral ischemia by regulating carnitine metabolism and angiogenesis via activating CPT1/HIF-1α signaling axis. Journal of ethnopharmacology · 10 Jul 2026 PMID 42431282
- Targeting SLK protects against cerebral ischemia-reperfusion injury by regulating USP8-mediated HIF-1α stabilization and RhoA/ROCK activation. Cellular & molecular biology letters · 2 Jul 2026 PMID 42387373
- Ophiopogon japonicus alleviates pulmonary fibrosis through modulation of HIF1A/TUBB3 axis-associated M2 macrophage polarization and arginine metabolic alterations. Journal of ethnopharmacology · 12 Jun 2026 PMID 42285238
Written from 13 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-08-26 by GPT. Reviewed by a human editor on 2026-07-24. Drafted by language models from published abstracts; not medical advice.